Neuropathic Pain Market Report 2021 to register a CAGR of 6.4% to reach US$ 9,862.3 Million by 2027, Global Industry Analysis, Growth, Size, Companies Revenue

SEATTLE, May 26, 2021, (MEDGADGET) — Overview

Neuropathic pain is a complex, long-term pain disorder that is often accompanied by tissue trauma. It can cause nerve fiber disruption, dysfunction, or injury, resulting in signal misfiring to other pain centers. A nerve fiber damage causes a difference in nerve activity both at the injury site and in the surrounding regions.

The global neuropathic pain market is expected to account for over US$ 6,313.4 Mn in terms of value in 2019 and is estimated to reach around US$ 9,862.3 Mn by the end of 2027.

Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3656

Global Neuropathic Pain Market: Drivers

Rising incidences of cancer is expected to drive growth of the global neuropathic pain market during the forecast period. For instance, in 2018, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide.

Furthermore, growing geriatric population is also expected to drive growth of the global neuropathic pain market. For instance, according to the World Health Organization, the global geriatric population will reach 2 billion by 2050, up from 900 million in 2015.

North America region held a significant position in the global neuropathic pain market in 2019, accounting for over 35.9% share in terms of value, followed by Europe.

Global Neuropathic Pain Market: Restraints 

Incomplete pain relief is expected to hamper growth of the global neuropathic pain market over the forecast period. For instance, using powerful medications like oxycodone to relieve neuropathic pain frequently results in a slight reduction in pain.

Furthermore, drug side effects are also expected to hinder growth of the global neuropathic pain market over the forecast period.  Opioids and steroids can cause problems including heart disease, kidney failure, and lung injury.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3656

Global Neuropathic Pain Market: Opportunities

Growing incidences of neuropathic-like pain in psoriatic arthritis is expected to pose attractive growth opportunities for players in the global neuropathic pain market. For instance, in July 2019, researchers from Cardiff University, U.K., reported that, in patients with psoriatic arthritis, neuropathic-like pain as indication of irregular pain perception is typical.

Furthermore, growing R&D in neuropathic pain is also expected to drive growth of the global neuropathic pain market. For instance, in March 2020, researchers from Heidelberg University, Germany, reported that an aqueous ethanol extract of Haematoxylon campechianum flowers was evaluated for phytochemical composition and potential prophylactic effects on peripheral neuropathic pain in a chronic constriction injury rat model.

Anticonvulsants segment in the global neuropathic pain market was accounted around US$ 2,548.1 Mn in 2019 and is expected to reach over US$ 4,310.3 Mn by 2027 at a CAGR around 6.4% over the forecast period.

Market Trends/Key Takeaways

Neuropathic discomfort caused by spared nerve damage, spinal nerve ligation, incomplete sciatic nerve injury, diabetes-induced neuropathy, chemotherapy-induced neuropathy, and permanent constriction injury will all be treated with flavonoids.

Electroacupuncture has been shown to be efficient in reducing neuropathic pain in several trials. For instance, in January 2020, researchers from Huazhong Agricultural University, China, demonstrated that Synaptotagmin 1 (Syt-1), a synaptic vesicle protein that regulates neurotransmitter exocytosis, impairs neuropathic pain, and electroacupuncture relieves it by down-regulating spinal exocytosis. Syt-1 is a genetically modified organism.

Global Neuropathic Pain Market: Competitive Landscape 

Key players are dominating in the global neuropathic pain market such as Johnson & Johnson Services, Inc., Pfizer, Inc., Sanofi S.A., GlaxoSmithKline PLC, Eli Lily and Company, Biogen Idec., Baxter Healthcare Corporation, Bristol-Myers Sqibb, and Depomed, Inc.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/neuropathic-pain-market-2949

Global Neuropathic Pain Market: Key Developments

Key players in the global neuropathic pain market are concentrating on having novel products accepted and released, to broaden their product range. For instance, in March 2020, Senzer Pharmaceuticals received the Investigational Experimental Drug application and data kit for its current FDA registration scheme from a former US strategic partner in order to gain clearance for its cannabinoid ventilation system for the treatment of anti-cancer treatment side effects, primarily nausea, vomiting, and neuropathic pain.

Key players in the global neuropathic pain market are concentrating on conducting clinical trials, to broaden their product range. For instance, in February 2020, in a multicenter, randomized trial, NoNO Inc., a privately owned biotechnology firm, announced that a novel peptide, nerinetide, showed medically significant changes in patients with acute ischemic stroke without previous administration of alteplase.

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Indication
     • Market Snippet, By Distribution Channel
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • PEST Analysis
   • Pipeline Analysis
4. Global Neuropathic Pain Market, By Drug Class, 2019 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Tricyclic Anti-Depressant
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Anticonvulsant
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Local Anaesthesia
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Opioids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Steroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
5. Global Neuropathic Pain Market, By Indication, 2019 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Diabetic neuropathy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Chemotherapy-induced Peripheral neuropathy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Other
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Neuropathic Pain Market, By Distribution Channel, 2019 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Drug Store
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
7. Global Neuropathic Pain Market, By Regions, 2019 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
       • North Africa
       • Central Africa
       • South Africa
8. Competitive Landscape
   • Company Profiles
9. Section
   • References
   • Research Methodology
   • About us and Sales Contact

Other Exclusive Reports:

Amitriptyline Market, By Strength, By Indication, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

Aromatherapy Market, by Product Type, by Application, by Mode of Delivery, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

Peripheral Neuropathy Treatment Market, by Type, by Treatment, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

Methadone Hydrochloride Market, by Formulation, by Application, by Route of Administration, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

Spinal Cord Injury Therapeutics Market, by Injury Type, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837